W. J. GREENLEE

1.4k total citations
21 papers, 573 citations indexed

About

W. J. GREENLEE is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, W. J. GREENLEE has authored 21 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in W. J. GREENLEE's work include Receptor Mechanisms and Signaling (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and Biological Evaluation (6 papers). W. J. GREENLEE is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and Biological Evaluation (6 papers). W. J. GREENLEE collaborates with scholars based in United States. W. J. GREENLEE's co-authors include Victor J. Lotti, David Hangauer, Peter K. S. Siegl, R S Chang, Nathan B. Mantlo, Probir Chakravarty, A. A. PATCHETT, Gilbert Stork, Yoshiaki Nakahara and Yuko Nakahara and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

W. J. GREENLEE

21 papers receiving 540 citations

Peers

W. J. GREENLEE
Debra L. Ondeyka United States
John S. Major United Kingdom
Paula Savage United States
S. KLUTCHKO United States
Bryan K. Sorensen United States
Kristie A. Faust United States
William C. Patt United States
Eddie C.‐K. Liu United States
Ligaya M. Simpkins United States
Hartmut Schirok Germany
Debra L. Ondeyka United States
W. J. GREENLEE
Citations per year, relative to W. J. GREENLEE W. J. GREENLEE (= 1×) peers Debra L. Ondeyka

Countries citing papers authored by W. J. GREENLEE

Since Specialization
Citations

This map shows the geographic impact of W. J. GREENLEE's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. J. GREENLEE with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. J. GREENLEE more than expected).

Fields of papers citing papers by W. J. GREENLEE

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. J. GREENLEE. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. J. GREENLEE. The network helps show where W. J. GREENLEE may publish in the future.

Co-authorship network of co-authors of W. J. GREENLEE

This figure shows the co-authorship network connecting the top 25 collaborators of W. J. GREENLEE. A scholar is included among the top collaborators of W. J. GREENLEE based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. J. GREENLEE. W. J. GREENLEE is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laszlo, Stephen E. de, Ralph A. Rivero, Lorraine Malkowitz, et al.. (1997). A nonpeptidic agonist ligand of the human C5a receptor: Synthesis, binding affinity optimization and functional characterization. Bioorganic & Medicinal Chemistry Letters. 7(2). 213–218. 15 indexed citations
2.
Chang, Linda, Wallace T. Ashton, Stacey O’Malley, et al.. (1996). ChemInform Abstract: Potent and Orally Active Angiotensin II Receptor Antagonists with Equal Affinity for Human AT1 and AT2 Subtypes.. ChemInform. 27(3). 1 indexed citations
3.
Walsh, Thomas F., Arthur A. Patchett, Raymond S.L. Chang, et al.. (1995). AT1 selective angiotensin II antagonists with phenoxyphenylacetic acid as a biphenyl replacement part I. Bioorganic & Medicinal Chemistry Letters. 5(2). 155–158. 7 indexed citations
4.
Kivlighn, Salah D., William R. Huckle, Gloria J. Zingaro, et al.. (1995). Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 268(3). R820–R823. 30 indexed citations
5.
Chang, Linda, Wallace T. Ashton, Ralph A. Rivero, et al.. (1994). Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypes. Bioorganic & Medicinal Chemistry Letters. 4(23). 2787–2792. 8 indexed citations
6.
Kim, Dooseop, Nathan B. Mantlo, Raymond S.L. Chang, Salah D. Kivlighn, & W. J. GREENLEE. (1994). Evaluation of heterocyclic acid equivalents as tetrazole replacements in imidazopyridine-based nonpeptide angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 41–44. 10 indexed citations
7.
Rivero, Ralph A., et al.. (1994). Subtituted phenylthiophene benzoylsulfonamides with potent binding affinity to angiotensin II AT1 and AT2 receptors. Bioorganic & Medicinal Chemistry Letters. 4(1). 189–194. 18 indexed citations
8.
Ashton, Wallace T., Steven M. Hutchins, W. J. GREENLEE, et al.. (1994). ChemInform Abstract: Nonpeptide Angiotensin II Antagonists Derived from 1H‐Pyrazole‐5‐ carboxylates and 4‐Aryl‐1H‐imidazole‐5‐carboxylates.. ChemInform. 25(13). 2 indexed citations
9.
Ashton, Wallace T., Steven M. Hutchins, W. J. GREENLEE, et al.. (1993). Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates. Journal of Medicinal Chemistry. 36(23). 3595–3605. 45 indexed citations
10.
Siegl, Peter K. S., R S Chang, Nathan B. Mantlo, et al.. (1992). In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 262(1). 139–144. 88 indexed citations
11.
Laszlo, Stephen E. de, Bruce L. Bush, John Doyle, et al.. (1992). Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors. Journal of Medicinal Chemistry. 35(5). 833–846. 41 indexed citations
12.
Chang, R S, Peter K. S. Siegl, Bradley V. Clineschmidt, et al.. (1992). In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 262(1). 133–138. 98 indexed citations
13.
Rivero, Ralph A. & W. J. GREENLEE. (1991). The synthesis of novel macrocyclic inhibitors of human renin. Tetrahedron Letters. 32(22). 2453–2456. 13 indexed citations
14.
Thornberry, Nancy A., Herbert G. Bull, D. Taub, et al.. (1988). ChemInform Abstract: 3‐Halovinylglycines. Efficient Irreversible Inhibitors of E. coli Alanine Racemase.. ChemInform. 19(11). 1 indexed citations
15.
GREENLEE, W. J. & David Hangauer. (1983). Addition of trimethylsilyl cyanide to α-substituted ketones: Catalyst efficiency. Tetrahedron Letters. 24(42). 4559–4560. 50 indexed citations
16.
GREENLEE, W. J. & R. B. Woodward. (1980). Marasmic acid—I. Tetrahedron. 36(23). 3361–3366. 7 indexed citations
17.
GREENLEE, W. J. & R. B. Woodward. (1980). Marasmic acid—II. Tetrahedron. 36(23). 3367–3375. 16 indexed citations
18.
Stork, Gilbert, Yoshiaki Nakahara, Yuko Nakahara, & W. J. GREENLEE. (1978). Total synthesis of cytochalasin B. Journal of the American Chemical Society. 100(24). 7775–7777. 76 indexed citations
19.
GREENLEE, W. J., D. Taub, & Arthur A. Patchett. (1978). A general synthesis of α-vinyl-α-amino acids. Tetrahedron Letters. 19(42). 3999–4002. 15 indexed citations
20.
Meerwall, E. von, et al.. (1974). Mössbauer Study of Dehydro-N N′ N″-Trialkylguanidino-hexacarbonyldi-iron(O) and Related Compounds. Spectroscopy Letters. 7(7). 311–317. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Debra L. Ondeyka Breakdown of academic impact, for papers by John S. Major Breakdown of academic impact, for papers by Paula Savage Breakdown of academic impact, for papers by S. KLUTCHKO Breakdown of academic impact, for papers by Bryan K. Sorensen Breakdown of academic impact, for papers by Kristie A. Faust Breakdown of academic impact, for papers by William C. Patt Breakdown of academic impact, for papers by Eddie C.‐K. Liu Breakdown of academic impact, for papers by Ligaya M. Simpkins Breakdown of academic impact, for papers by Hartmut Schirok
Rankless by CCL
2026